The University of Texas Southwestern Medical Center
Dallas, Texas, 75235, United States
NCT Number: NCT04600609
This is a 3-phase mixed methods study design. A literature review (Phase 1) has been completed to determine the areas of exploration and to identify challenges faced and the impact of the blood disorder on pediatric patients. Based on Phase 1, Phases 2 and 3, as proposed in this study, will be completed and will include interviews of patients diagnosed with bleeding and thrombotic disorders (phase 2). The interviews will be individual, semi-structured, and consist of open-ended questions to elicit unbiased and in-depth responses to gain an understanding of participant's perspectives on themes predetermined in the study design phase.
Looking for future studies?
Notify Me12 year–21 year
All sexes
Observational
Dallas, Texas, 75235, United States
The purpose of this study is to explore the experiences of pediatric patients with blood disorders, specifically thrombotic, including venous thromboembolism (VTE), and hemostatic or bleeding disorders. The information gleaned from this study will help identify specific challenges faced by patients with hemostatic and thrombotic disorders - information that is necessary to develop impactful, evidence-based solutions to support patients with hemostatic and thrombotic disorders cope with the physical, emotional, and psychological impact of blood disorders. Participants with blood disorders in this study will participate in open-ended, semi-structured interviews with a study investigator focusing on the psychosocial experiences of patients with diagnosis and treatment of their underlying disorder and the understanding of their diagnosis. Female participants additionally will be asked questions about the unique effects of heavy menstrual bleeding, either from their underlying blood disorder or secondary to anticoagulation, on similar aspects of the impact of having a blood disorder. Validated questionnaires will be completed to obtain concurrent quantitative data. The interviews will be recorded and transcribed. Participation is complete after the interview has finished; participants will continue to receive standard of care treatment during and beyond the study period.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within 1 year of diagnosis for clot patients; after formal diagnosis for bleeding disorder patients
Effect of blood disorder diagnosis on quality of life will be measured using Pediatric Quality of Life Questionnaire, Menorrhagia Impact Questionnaire, and Godin Physical Activity Questionnaire
Time frame: Within 1 year of diagnosis for clot patients; after formal diagnosis for bleeding disorder patients
Patient confidence in managing blood disorder and recognizing emergencies will be assessed using a semi-structured interview with the patient
Time frame: Within 1 year of diagnosis for clot patients; after formal diagnosis for bleeding disorder patients
Impressions of quality of care received in a specialized bleeding disorders and thrombosis clinic will be assessed using a semi-structured interview with the patient
Time frame: Within 1 year of diagnosis for clot patients; after formal diagnosis for bleeding disorder patients
Patient's reaction to the diagnosis and its impact on their future will be assessed using a semi-structured interview with the patient
Time frame: Within 1 year of diagnosis for clot patients; after formal diagnosis for bleeding disorder patients
Screening completed using PHQ-9 questionnaire
Time frame: Within 1 year of diagnosis for clot patients; after formal diagnosis for bleeding disorder patients
Screening completed using Peds QOL questionnaire
Time frame: Within 1 year of diagnosis for clot patients; after formal diagnosis for bleeding disorder patients
Screening completed using Menorrhagia impact questionnaire
Time frame: Within 1 year of diagnosis for clot patients; after formal diagnosis for bleeding disorder patients
Screening completed using Dalhousie Dypsnea questionnaire
Time frame: Within 1 year of diagnosis for clot patients; after formal diagnosis for bleeding disorder patients
Screening completed using Godin Physical Activity questionnaire
University of Texas Southwestern Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05305534
Blood Disease, Hematologic Diseases
Manchester, United Kingdom
View Trial DetailsNCT04737785
Blood Cancer, Blood Disease
Westmead, Australia
View Trial DetailsNCT06471478
Blood Disease, Hematologic Diseases
Kunming, Yunnan, China
View Trial DetailsNCT00000587
Acquired Immunodeficiency Syndrome, Anemia
View Trial Details